volume 25 issue 7 pages 792-798

Resistance of Candida to azoles and echinocandins worldwide.

Publication typeJournal Article
Publication date2019-07-01
scimago Q1
wos Q1
SJR2.742
CiteScore22.4
Impact factor8.5
ISSN1198743X, 14690691
General Medicine
Microbiology (medical)
Infectious Diseases
Abstract
Recently there has been an increase in Candida infections worldwide. A handful of species in the genus Candida are opportunistic pathogens and have been known to cause infections in immunocompromised or otherwise impaired hosts. These infections can be superficial, affecting the skin or mucous membrane, or invasive, which can be life-threatening. Azoles and echinocandins are antifungal drugs used globally to treat Candida infections. However, resistance to these antifungal drugs has increased in many of the Candida species, and the effects this has in the clinical setting can be seen.Here, we discuss the mechanisms that Candida albicans, Candida dubliniensis, Candida glabrata, Candida parapsilosis, Candida tropicalis and Candida auris are implementing to increase resistance to azoles and echinocandins, and how they are affecting clinical, or hospital, settings worldwide.Different studies and papers describing the mechanisms of antifungal drugs and Candida species evolution to becoming resistant to these drugs were looked at for this review.We discuss the mechanisms that azoles and echinocandins use against Candida species to treat infections, as well as the evolution of these fungi to become resistant to these drugs, and the effect this has in the clinical settings around the globe.Increased resistance to azoles and echinocandins by Candida species is an increasingly serious problem in clinical settings worldwide. Understanding the mechanisms used against antifungal drugs is imperative for patient treatment.
Found 
Found 

Top-30

Journals

5
10
15
20
25
30
35
40
Journal of Fungi
38 publications, 7.01%
Antibiotics
19 publications, 3.51%
Molecules
13 publications, 2.4%
Microbiology spectrum
12 publications, 2.21%
Pharmaceutics
10 publications, 1.85%
Microorganisms
10 publications, 1.85%
Frontiers in Microbiology
10 publications, 1.85%
International Journal of Molecular Sciences
9 publications, 1.66%
Scientific Reports
8 publications, 1.48%
Brazilian Journal of Microbiology
8 publications, 1.48%
Future Microbiology
7 publications, 1.29%
Microbial Pathogenesis
7 publications, 1.29%
Mycoses
7 publications, 1.29%
Medical Mycology
7 publications, 1.29%
Antimicrobial Agents and Chemotherapy
7 publications, 1.29%
Pathogens
5 publications, 0.92%
Frontiers in Cellular and Infection Microbiology
5 publications, 0.92%
Infection and Drug Resistance
5 publications, 0.92%
Virulence
5 publications, 0.92%
Expert Review of Anti-Infective Therapy
5 publications, 0.92%
Journal of Medical Microbiology
4 publications, 0.74%
World Journal of Microbiology and Biotechnology
4 publications, 0.74%
European Journal of Medicinal Chemistry
4 publications, 0.74%
PLoS ONE
4 publications, 0.74%
Journal of Applied Microbiology
4 publications, 0.74%
Cureus
4 publications, 0.74%
Marine Drugs
3 publications, 0.55%
Pharmaceuticals
3 publications, 0.55%
Frontiers in Pharmacology
3 publications, 0.55%
5
10
15
20
25
30
35
40

Publishers

20
40
60
80
100
120
140
MDPI
134 publications, 24.72%
Springer Nature
91 publications, 16.79%
Elsevier
90 publications, 16.61%
Taylor & Francis
40 publications, 7.38%
Wiley
32 publications, 5.9%
American Society for Microbiology
23 publications, 4.24%
Frontiers Media S.A.
22 publications, 4.06%
Oxford University Press
20 publications, 3.69%
Cold Spring Harbor Laboratory
14 publications, 2.58%
American Chemical Society (ACS)
8 publications, 1.48%
Public Library of Science (PLoS)
6 publications, 1.11%
Microbiology Society
5 publications, 0.92%
Hindawi Limited
4 publications, 0.74%
Bentham Science Publishers Ltd.
3 publications, 0.55%
Ovid Technologies (Wolters Kluwer Health)
3 publications, 0.55%
SAGE
3 publications, 0.55%
Brieflands
3 publications, 0.55%
American Association for the Advancement of Science (AAAS)
2 publications, 0.37%
Royal Society of Chemistry (RSC)
2 publications, 0.37%
Mary Ann Liebert
2 publications, 0.37%
Georg Thieme Verlag KG
2 publications, 0.37%
Research Square Platform LLC
2 publications, 0.37%
IntechOpen
2 publications, 0.37%
Canadian Science Publishing
1 publication, 0.18%
Portland Press
1 publication, 0.18%
Han-Gug Misaengmul Hag-hoe/The Microbiological Society of Korea
1 publication, 0.18%
King Saud University
1 publication, 0.18%
Walter de Gruyter
1 publication, 0.18%
Scientific Research Publishing
1 publication, 0.18%
20
40
60
80
100
120
140
  • We do not take into account publications without a DOI.
  • Statistics recalculated weekly.

Are you a researcher?

Create a profile to get free access to personal recommendations for colleagues and new articles.
Metrics
542
Share
Cite this
GOST |
Cite this
GOST Copy
Pristov K. E., Ghannoum M. A. Resistance of Candida to azoles and echinocandins worldwide. // Clinical Microbiology and Infection. 2019. Vol. 25. No. 7. pp. 792-798.
GOST all authors (up to 50) Copy
Pristov K. E., Ghannoum M. A. Resistance of Candida to azoles and echinocandins worldwide. // Clinical Microbiology and Infection. 2019. Vol. 25. No. 7. pp. 792-798.
RIS |
Cite this
RIS Copy
TY - JOUR
DO - 10.1016/j.cmi.2019.03.028
UR - https://doi.org/10.1016/j.cmi.2019.03.028
TI - Resistance of Candida to azoles and echinocandins worldwide.
T2 - Clinical Microbiology and Infection
AU - Pristov, K E
AU - Ghannoum, M A
PY - 2019
DA - 2019/07/01
PB - Elsevier
SP - 792-798
IS - 7
VL - 25
PMID - 30965100
SN - 1198-743X
SN - 1469-0691
ER -
BibTex |
Cite this
BibTex (up to 50 authors) Copy
@article{2019_Pristov,
author = {K E Pristov and M A Ghannoum},
title = {Resistance of Candida to azoles and echinocandins worldwide.},
journal = {Clinical Microbiology and Infection},
year = {2019},
volume = {25},
publisher = {Elsevier},
month = {jul},
url = {https://doi.org/10.1016/j.cmi.2019.03.028},
number = {7},
pages = {792--798},
doi = {10.1016/j.cmi.2019.03.028}
}
MLA
Cite this
MLA Copy
Pristov, K. E., and M A Ghannoum. “Resistance of Candida to azoles and echinocandins worldwide..” Clinical Microbiology and Infection, vol. 25, no. 7, Jul. 2019, pp. 792-798. https://doi.org/10.1016/j.cmi.2019.03.028.